交易 Natera, Inc. - NTRA CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
交易条件
价差 | - | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.024068% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.001846% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平倉 | Change | Change (%) | 開倉 | High | Low |
---|
Natera, Inc. Events
時間(協調世界時) (UTC) | 國家 | 事件 |
---|---|---|
No events scheduled |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
总收入 | 625.486 | 391.005 | 302.328 | 257.654 | 209.625 |
收入 | 625.486 | 391.005 | 302.328 | 257.654 | 209.625 |
收入成本,共计 | 318.418 | 203.62 | 175.47 | 166.055 | 139.596 |
毛利 | 307.068 | 187.385 | 126.858 | 91.599 | 70.029 |
总营业费用 | 1093.66 | 613.13 | 418.615 | 372.282 | 344.966 |
销售/一般/行政费用,总计 | 511.034 | 303.627 | 204.476 | 154.872 | 155.306 |
研究与开发 | 264.208 | 100.035 | 51.357 | 51.355 | 50.064 |
营业收入 | -468.174 | -222.125 | -116.287 | -114.628 | -135.341 |
利息收入(费用),非经营净值 | -8.305 | -15.082 | -10.693 | -10.476 | -4.213 |
其他,净值 | 5.381 | 7.562 | 4.152 | -2.729 | 2.38 |
税前净收入 | -471.098 | -229.645 | -122.828 | -127.833 | -137.174 |
税后净收入 | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
未计算非常项目前的净收益 | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
净收入 | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
普通股股东可获收益 (不含非经常性项目) | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
普通股股东可获收益 (含非經常性項目) | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
摊薄净收入 | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
摊薄后加权平均股 | 90.558 | 81.011 | 69.555 | 57.848 | 53.312 |
扣除特别项目的每股摊薄盈利 | -5.20899 | -2.83595 | -1.79465 | -2.21536 | -2.58156 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
每股正常摊薄盈利 | -5.20899 | -2.78903 | -1.91322 | -2.21536 | -2.58156 |
非常规项目总计 | 0 | ||||
异常费用(收入) | 0 | 5.848 | -12.688 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
总收入 | 194.133 | 173.028 | 158.116 | 142.026 | 152.316 |
收入 | 194.133 | 173.028 | 158.116 | 142.026 | 152.316 |
收入成本,共计 | 103.215 | 94.122 | 81.371 | 76.112 | 66.813 |
毛利 | 90.918 | 78.906 | 76.745 | 65.914 | 85.503 |
总营业费用 | 331.263 | 312.694 | 308.313 | 257.32 | 215.333 |
销售/一般/行政费用,总计 | 147.634 | 146.761 | 128.485 | 127.456 | 108.332 |
研究与开发 | 80.414 | 71.811 | 98.457 | 53.752 | 40.188 |
营业收入 | -137.13 | -139.666 | -150.197 | -115.294 | -63.017 |
利息收入(费用),非经营净值 | -2.087 | -2.079 | -2.078 | -2.075 | -2.073 |
其他,净值 | 0.801 | 1.151 | 1.274 | 1.585 | 1.371 |
税前净收入 | -138.416 | -140.594 | -151.001 | -115.784 | -63.719 |
税后净收入 | -138.595 | -140.564 | -151.273 | -116.026 | -63.853 |
未计算非常项目前的净收益 | -138.595 | -140.564 | -151.273 | -116.026 | -63.853 |
净收入 | -138.595 | -140.564 | -151.273 | -116.026 | -63.853 |
普通股股东可获收益 (不含非经常性项目) | -138.595 | -140.564 | -151.273 | -116.026 | -63.853 |
普通股股东可获收益 (含非經常性項目) | -138.595 | -140.564 | -151.273 | -116.026 | -63.853 |
摊薄净收入 | -138.595 | -140.564 | -151.273 | -116.026 | -63.853 |
摊薄后加权平均股 | 95.578 | 94.842 | 92.558 | 88.077 | 86.689 |
扣除特别项目的每股摊薄盈利 | -1.45007 | -1.48209 | -1.63436 | -1.31732 | -0.73658 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | -1.45007 | -1.48209 | -1.63436 | -1.31732 | -0.73658 |
异常费用(收入) | 0 | 0 | 0 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
流动资产总额 | 1093.14 | 862.663 | 523.167 | 240.518 | 180.625 |
现金和短期投资 | 914.282 | 737.274 | 440.991 | 153.868 | 118.867 |
现金等价物 | 84.386 | 48.668 | 61.926 | 46.407 | 12.62 |
短期投资 | 829.896 | 688.606 | 379.065 | 107.461 | 106.247 |
应收账款总额,净额 | 122.074 | 78.565 | 53.351 | 62.223 | 44.089 |
Accounts Receivable - Trade, Net | 122.074 | 78.565 | 53.351 | 62.223 | 44.089 |
Total Inventory | 26.909 | 20.031 | 12.394 | 13.633 | 8.998 |
Prepaid Expenses | 29.645 | 26.606 | 16.376 | 6.197 | 8.612 |
Other Current Assets, Total | 0.228 | 0.187 | 0.055 | 4.597 | 0.059 |
Total Assets | 1236.49 | 932.153 | 582.656 | 268.171 | 214.613 |
Property/Plant/Equipment, Total - Net | 124.529 | 54.747 | 47.013 | 24.336 | 29.667 |
Property/Plant/Equipment, Total - Gross | 143.942 | 104.801 | 88.537 | 58.633 | 56.652 |
Accumulated Depreciation, Total | -19.413 | -50.054 | -41.524 | -34.297 | -26.985 |
Other Long Term Assets, Total | 18.82 | 14.743 | 12.476 | 3.317 | 4.321 |
Total Current Liabilities | 218.956 | 199.053 | 179.874 | 113.981 | 105.561 |
Accounts Payable | 27.206 | 8.096 | 8.604 | 14.587 | 8.529 |
Accrued Expenses | 114.854 | 71.689 | 54.03 | 33.843 | 35.558 |
Notes Payable/Short Term Debt | 50.052 | 50.054 | 50.123 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 50.153 | 50.112 | |||
Other Current Liabilities, Total | 26.844 | 69.214 | 67.117 | 15.398 | 11.362 |
Total Liabilities | 583.183 | 445.917 | 303.945 | 236.009 | 189.196 |
Total Long Term Debt | 280.394 | 202.493 | 73.656 | 73.357 | 73.065 |
Other Liabilities, Total | 83.833 | 44.371 | 50.415 | 48.671 | 10.57 |
Total Equity | 653.304 | 486.236 | 278.711 | 32.162 | 25.417 |
Preferred Stock - Non Redeemable, Net | 0 | ||||
Common Stock | 0.01 | 0.009 | 0.008 | 0.007 | 0.006 |
Additional Paid-In Capital | 2050.42 | 1411.29 | 976.955 | 607.236 | 472.552 |
Retained Earnings (Accumulated Deficit) | -1394.84 | -929.318 | -699.171 | -574.529 | -446.375 |
Other Equity, Total | -2.287 | 4.259 | 0.919 | -0.552 | -0.766 |
Total Liabilities & Shareholders’ Equity | 1236.49 | 932.153 | 582.656 | 268.171 | 214.613 |
Total Common Shares Outstanding | 95.14 | 86.223 | 78.005 | 62.083 | 54.04 |
Long Term Debt | 280.394 | 202.493 | 73.656 | 73.357 | 73.065 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
流动资产总额 | 980.226 | 1093.14 | 1191.22 | 739.888 | 791.403 |
现金和短期投资 | 751.958 | 914.282 | 1023.7 | 580.243 | 653.572 |
现金等价物 | 158.298 | 84.386 | 95.103 | 62.811 | 65.126 |
短期投资 | 593.66 | 829.896 | 928.596 | 517.432 | 588.446 |
应收账款总额,净额 | 167.862 | 122.074 | 110.416 | 100.13 | 87.562 |
Accounts Receivable - Trade, Net | 167.862 | 122.074 | 110.416 | 100.13 | 87.562 |
Total Inventory | 25.048 | 26.909 | 28.022 | 28.409 | 23.676 |
Prepaid Expenses | 35.13 | 29.645 | 28.858 | 30.878 | 26.43 |
Other Current Assets, Total | 0.228 | 0.228 | 0.228 | 0.228 | 0.163 |
Total Assets | 1144.66 | 1236.49 | 1311.37 | 849.956 | 893.512 |
Property/Plant/Equipment, Total - Net | 142.762 | 124.529 | 106.949 | 97.221 | 89.703 |
Property/Plant/Equipment, Total - Gross | 165.177 | 143.942 | 165.263 | 152.538 | 142.306 |
Accumulated Depreciation, Total | -22.415 | -19.413 | -58.314 | -55.317 | -52.603 |
Other Long Term Assets, Total | 21.676 | 18.82 | 13.202 | 12.847 | 12.406 |
Total Current Liabilities | 231.072 | 218.956 | 199.714 | 197.988 | 166.969 |
Accounts Payable | 18.07 | 27.206 | 8.181 | 20.307 | 4.682 |
Accrued Expenses | 130.919 | 114.854 | 114.18 | 93.183 | 81.711 |
Notes Payable/Short Term Debt | 50.055 | 50.052 | 50.049 | 50.049 | 50.052 |
Other Current Liabilities, Total | 32.028 | 26.844 | 27.304 | 34.449 | 30.524 |
Total Liabilities | 602.329 | 583.183 | 552.357 | 550.846 | 521.067 |
Total Long Term Debt | 280.706 | 280.394 | 280.085 | 279.777 | 279.471 |
Long Term Debt | 280.706 | 280.394 | 280.085 | 279.777 | 279.471 |
Other Liabilities, Total | 90.551 | 83.833 | 72.558 | 73.081 | 74.627 |
Total Equity | 542.335 | 653.304 | 759.017 | 299.11 | 372.445 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.009 | 0.009 |
Additional Paid-In Capital | 2089.66 | 2050.42 | 2011.79 | 1399.66 | 1356.21 |
Retained Earnings (Accumulated Deficit) | -1533.43 | -1394.84 | -1254.27 | -1103 | -986.973 |
Other Equity, Total | -13.904 | -2.287 | 1.491 | 2.441 | 3.197 |
Total Liabilities & Shareholders’ Equity | 1144.66 | 1236.49 | 1311.37 | 849.956 | 893.512 |
Total Common Shares Outstanding | 96.259 | 95.14 | 94.538 | 88.498 | 87.43 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
净收入/起跑线 | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
经营活动产生的现金 | -335.236 | -182.512 | -63.444 | -70.581 | -97.825 |
经营活动产生的现金 | 11.254 | 8.613 | 7.73 | 7.501 | 7.143 |
非现金物品 | 171.299 | 77.748 | 26.452 | 22.916 | 13.05 |
Cash Taxes Paid | 0.283 | 0.067 | 2.154 | 0.332 | 0.177 |
已付现金利息 | 7.077 | 3.296 | 12.455 | 7.914 | 3.568 |
营运资金的变化 | -46.073 | -39.13 | 27.201 | 27.156 | 19.61 |
投资活动产生的现金 | -205.193 | -331.461 | -266.353 | -5.161 | 13.784 |
资本支出 | -49.588 | -19.604 | -4.968 | -3.88 | -9.867 |
其他投资现金流量项目,总计 | -155.605 | -311.857 | -261.385 | -1.281 | 23.651 |
融资活动产生的现金 | 576.188 | 500.847 | 340.774 | 113.725 | 80.372 |
股票的发行(报废),净额 | 576.188 | 301.288 | 340.774 | 113.725 | 5.659 |
债务的发行(退还),净额 | 0 | 199.559 | 0 | 0 | 75 |
现金净变化 | 35.759 | -13.126 | 10.977 | 37.983 | -3.669 |
融资现金流项目 | 0 | -0.287 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -138.595 | -471.716 | -331.152 | -179.879 | -63.853 |
Cash From Operating Activities | -137.277 | -335.236 | -236.5 | -145.439 | -74.876 |
Cash From Operating Activities | 3.002 | 11.254 | 8.259 | 5.262 | 2.549 |
Non-Cash Items | 40.865 | 171.299 | 136.312 | 68.849 | 28.676 |
Cash Interest Paid | 0.159 | 7.077 | 3.69 | 3.538 | 0.152 |
Changes in Working Capital | -42.549 | -46.073 | -49.919 | -39.671 | -42.248 |
Cash From Investing Activities | 207.033 | -205.193 | -284.697 | 146.709 | 86.74 |
Capital Expenditures | -15.885 | -49.588 | -36.298 | -18.891 | -10.26 |
Other Investing Cash Flow Items, Total | 222.918 | -155.605 | -248.399 | 165.6 | 97 |
Cash From Financing Activities | 4.156 | 576.188 | 567.673 | 12.914 | 4.57 |
Issuance (Retirement) of Stock, Net | 4.156 | 576.188 | 567.673 | 12.914 | 4.57 |
Net Change in Cash | 73.912 | 35.759 | 46.476 | 14.184 | 16.434 |
Issuance (Retirement) of Debt, Net | 0 | 0 | 0 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.7594 | 9923131 | 1628200 | 2022-12-31 | LOW |
Fred Alger Management, LLC | Investment Advisor/Hedge Fund | 7.9205 | 8972823 | 191477 | 2022-12-31 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.2045 | 4763130 | 715214 | 2022-12-31 | LOW |
Samlyn Capital, LLC | Hedge Fund | 3.8755 | 4390372 | 2113236 | 2022-12-31 | HIGH |
JP Morgan Asset Management | Investment Advisor | 3.739 | 4235761 | 101390 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 3.1533 | 3572262 | 764812 | 2022-12-31 | LOW |
Sofinnova Investments, Inc | Venture Capital | 2.7369 | 3100560 | -2400 | 2022-12-31 | MED |
Citadel Advisors LLC | Hedge Fund | 2.6914 | 3048948 | 884865 | 2022-12-31 | HIGH |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.4544 | 2780428 | 1886903 | 2022-12-31 | LOW |
Eversept Partners, LP | Hedge Fund | 2.371 | 2685959 | 1260357 | 2022-12-31 | MED |
RTW Investments L.P. | Investment Advisor/Hedge Fund | 2.3033 | 2609283 | 400000 | 2022-12-31 | LOW |
Kynam Capital Management LP | Hedge Fund | 2.2979 | 2603207 | 584847 | 2022-12-31 | HIGH |
Principal Global Investors (Equity) | Investment Advisor | 1.7724 | 2007860 | 867205 | 2022-12-31 | LOW |
OrbiMed Advisors, LLC | Investment Advisor/Hedge Fund | 1.7181 | 1946353 | 441200 | 2022-12-31 | LOW |
Avidity Partners Management LP | Hedge Fund | 1.5879 | 1798900 | 63900 | 2022-12-31 | HIGH |
Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 1.5711 | 1779828 | 184128 | 2022-12-31 | LOW |
Braidwell LP | Hedge Fund | 1.4309 | 1621012 | 1621012 | 2022-12-31 | |
D. E. Shaw & Co., L.P. | Hedge Fund | 1.3493 | 1528566 | -53493 | 2022-12-31 | MED |
Marshall Wace LLP | Investment Advisor/Hedge Fund | 1.3171 | 1492125 | 262940 | 2022-12-31 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.3059 | 1479376 | 217067 | 2022-12-31 | LOW |
交易計算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
貿易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
開倉
平倉
做空 做多
Natera, Inc. Company profile
关于 Natera Inc.
Natera, Inc.是一家诊断学公司。 公司专注于分子测试服务的开发和商业化,将其技术应用于妇女健康、肿瘤学和器官健康领域。 公司的无细胞DNA(cfDNA)技术结合了其分子检测方法,可以从小到一个细胞的样本中可靠地测量整个基因组的许多信息区域。 公司的产品包括Panorama无创产前检测(NIPT)、Vistara、Horizon载体筛查(HCS)、Spectrum植入前遗传学(Spectrum)、Anora流产检测(Anora)、无创亲子检测(PAT)和Prospera。 公司还提供Constellation,这是一个基于云的软件平台,使实验室客户能够通过云获得公司的算法和生物信息学,以验证和推出基于公司技术的测试。
Industry: | Laboratory Diagnostic & Testing Substances |
13011 Mccallen Pass
Building A Suite 100
AUSTIN
TEXAS 78753
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。